430 related articles for article (PubMed ID: 27991925)
21. Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model.
Karthikeyan S; Russo A; Dean M; Lantvit DD; Endsley M; Burdette JE
Cancer Lett; 2018 Oct; 433():221-231. PubMed ID: 29981811
[TBL] [Abstract][Full Text] [Related]
22. High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.
Zhai Y; Wu R; Kuick R; Sessine MS; Schulman S; Green M; Fearon ER; Cho KR
J Pathol; 2017 Sep; 243(1):16-25. PubMed ID: 28608929
[TBL] [Abstract][Full Text] [Related]
23. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity.
Walton JB; Farquharson M; Mason S; Port J; Kruspig B; Dowson S; Stevenson D; Murphy D; Matzuk M; Kim J; Coffelt S; Blyth K; McNeish IA
Sci Rep; 2017 Dec; 7(1):16827. PubMed ID: 29203787
[TBL] [Abstract][Full Text] [Related]
25. Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer.
Al-Hujaily EM; Tang Y; Yao DS; Carmona E; Garson K; Vanderhyden BC
Cancer Prev Res (Phila); 2015 Dec; 8(12):1163-73. PubMed ID: 26373819
[TBL] [Abstract][Full Text] [Related]
26. YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.
Hua G; Lv X; He C; Remmenga SW; Rodabough KJ; Dong J; Yang L; Lele SM; Yang P; Zhou J; Karst A; Drapkin RI; Davis JS; Wang C
Oncogene; 2016 Apr; 35(17):2247-65. PubMed ID: 26364602
[TBL] [Abstract][Full Text] [Related]
27. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation.
Russo A; Czarnecki AA; Dean M; Modi DA; Lantvit DD; Hardy L; Baligod S; Davis DA; Wei JJ; Burdette JE
Oncogene; 2018 Apr; 37(15):1976-1990. PubMed ID: 29367766
[TBL] [Abstract][Full Text] [Related]
28. [The dualistic model and extraovarian origin theory of ovarian epithelial cancer].
Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):310-3. PubMed ID: 23902820
[No Abstract] [Full Text] [Related]
29. Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects.
Chu TY; Khine AA; Wu NY; Chen PC; Chu SC; Lee MH; Huang HS
Mol Carcinog; 2023 Sep; 62(9):1417-1427. PubMed ID: 37265438
[TBL] [Abstract][Full Text] [Related]
30. Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.
Dean M; Jin V; Russo A; Lantvit DD; Burdette JE
Carcinogenesis; 2019 Mar; 40(1):41-51. PubMed ID: 30475985
[TBL] [Abstract][Full Text] [Related]
31. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
Perets R; Wyant GA; Muto KW; Bijron JG; Poole BB; Chin KT; Chen JY; Ohman AW; Stepule CD; Kwak S; Karst AM; Hirsch MS; Setlur SR; Crum CP; Dinulescu DM; Drapkin R
Cancer Cell; 2013 Dec; 24(6):751-65. PubMed ID: 24332043
[TBL] [Abstract][Full Text] [Related]
32. The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice.
Kim J; Coffey DM; Ma L; Matzuk MM
Endocrinology; 2015 Jun; 156(6):1975-81. PubMed ID: 25815421
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma.
Sugimoto S; Uchiyama T; Kawahara N; Ohbayashi C; Kobayashi H
Int J Gynecol Pathol; 2021 Sep; 40(5):419-426. PubMed ID: 34397764
[TBL] [Abstract][Full Text] [Related]
34. High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis.
Hatano Y; Fukuda S; Makino H; Tomita H; Morishige KI; Hara A
Diagn Pathol; 2018 Apr; 13(1):24. PubMed ID: 29703236
[TBL] [Abstract][Full Text] [Related]
35. Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.
Dean M; Davis DA; Burdette JE
Cancer Lett; 2017 Apr; 391():114-124. PubMed ID: 28115208
[TBL] [Abstract][Full Text] [Related]
36. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
[TBL] [Abstract][Full Text] [Related]
37. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R
Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882
[TBL] [Abstract][Full Text] [Related]
38. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
[TBL] [Abstract][Full Text] [Related]
39. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.
Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R
Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162
[TBL] [Abstract][Full Text] [Related]
40. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
